JEV IgG/IgM Rapid Test
Rapid antibody screening for Japanese Encephalitis Virus (JEV) using human blood samples.
Product Overview
The JEV IgG/IgM Rapid Test is a cassette-based immunological screening device designed for the qualitative detection of IgG and IgM antibodies against Japanese Encephalitis Virus (JEV) in human blood samples.
Japanese encephalitis is a mosquito-borne viral disease that primarily affects the central nervous system. Detection of JEV-specific antibodies can support the immunological assessment of individuals with suspected exposure or infection.
Designed for use with whole blood, serum or plasma, this rapid test provides a convenient screening format for professional healthcare and diagnostic environments.
Key Features
- Qualitative detection of JEV-specific IgG and IgM antibodies.
- Designed for whole blood, serum and plasma samples.
- Convenient cassette-based test format.
- Suitable for professional diagnostic screening workflows.
- Supports preliminary immunological investigations.
- Supplied in a pack of 25 tests.
Applications
The JEV IgG/IgM Rapid Test is intended for preliminary antibody screening in professional settings, including:
- Clinical and diagnostic laboratories.
- Infectious disease screening workflows.
- Japanese encephalitis-related investigations.
- Healthcare and medical facilities.
- Professional immunological testing environments.
Technical Specifications
| Product Name | JEV IgG/IgM Rapid Test |
| Catalog Number | 1317-GS110430C |
| Pack Size | 25 Tests/box |
| Sample Type | Whole Blood / Serum / Plasma (WB/S/P) |
| Test Format | Cassette 4 mm |
| Storage Conditions | 0–40 °C |
| Dry Ice | No |
| Hazardous | No |
| Minimum Order Quantity | 1000 |
| Supplier | Riomavix Sociedad Limitada, Spain |
Storage and Handling
Store the JEV IgG/IgM Rapid Test within the recommended temperature range of 0–40 °C. Follow the manufacturer's instructions for sample collection, test preparation, handling and result interpretation.
Important Information
Detection of JEV-specific antibodies should be interpreted in conjunction with clinical findings, epidemiological information and other laboratory investigations. IgM antibodies may support the assessment of recent infection, while IgG antibodies may indicate previous exposure or an immune response. Cross-reactivity with other flaviviruses, including dengue and Zika viruses, may affect interpretation. Confirmatory testing may be necessary. This screening test should not be used as the sole basis for diagnosis.
Order JEV IgG/IgM Rapid Test
Discover rapid diagnostic tests and laboratory products through Gentaur.
SHOP NOW